Ricinoleic acid 98%
Price | Get Latest Price | ||||
Packge | 1MT | 1kg | 5kg | 10kg | 25kg |
- Min. Order:1MT
- Time:2024-03-04
Product Details
- Product NameRicinoleic acid
- CAS No.141-22-0
- EINECS No.205-470-2
- MFC18H34O3
- MW298.46
- InChIKeyWBHHMMIMDMUBKC-QJWNTBNXSA-N
- AppearanceLiquidColorless to Red to Green
- density 0.940 g/mL at 20 °C(lit.)
- storage temp. -20°C
- Melting point 22.5-24.5℃
- Boiling point bp10 245°
Company Profile Introduction
Pushing the boundaries of Science & Technology to deliver cost effective life science products.
While we continue to thrive on Research & Innovation as our fundamental base to enter into the next phase of our growth, we also look to focus on strategic collaborations & leveraging our global customer base to bring sales growth & improved profatibility.
Established 2016HO in Vashi, Mumbai. Manufacturing unit in Pune Maharashtra. Operating in 5 verticals – Active Pharmaceutical Ingredients (APIs), Intermediates & Spec. Chemicals, Finished Dosage Formulations.
Complex ChemSuccessfully demonstrated the ability to handle complex & haz. Chemistries. Multi step synthesis identified as important differentiator for growth.
Global PlayerServing global customers. Exporting to more than 25 countries. Strong position in Oxicam Series (Lornoxicam, Meloxicam, Piroxicam, Piroxicam BCD, Tenoxicam) & Bromhexine. More than 60% revenue from Exports. 250+ customers.
Research DrivenInnovation based approach to be the best in segment. Backward integrated API & FDF as growth drivers. Flow chemistry and micro reactors for new innovations.
CertificationsISO 9001, 140001, 18001, Halal certified. FDA & GMP for API mfg. Planning to obtain WHO GMP by 2024.
Competent TeamPromoters are from ICT (Formerly known as UDCT). Competent and experienced leadership team to steer growth
While we continue to thrive on Research & Innovation as our fundamental base to enter into the next phase of our growth, we also look to focus on strategic collaborations & leveraging our global customer base to bring sales growth & improved profatibility.
Established 2016HO in Vashi, Mumbai. Manufacturing unit in Pune Maharashtra. Operating in 5 verticals – Active Pharmaceutical Ingredients (APIs), Intermediates & Spec. Chemicals, Finished Dosage Formulations.
Complex ChemSuccessfully demonstrated the ability to handle complex & haz. Chemistries. Multi step synthesis identified as important differentiator for growth.
Global PlayerServing global customers. Exporting to more than 25 countries. Strong position in Oxicam Series (Lornoxicam, Meloxicam, Piroxicam, Piroxicam BCD, Tenoxicam) & Bromhexine. More than 60% revenue from Exports. 250+ customers.
Research DrivenInnovation based approach to be the best in segment. Backward integrated API & FDF as growth drivers. Flow chemistry and micro reactors for new innovations.
CertificationsISO 9001, 140001, 18001, Halal certified. FDA & GMP for API mfg. Planning to obtain WHO GMP by 2024.
Competent TeamPromoters are from ICT (Formerly known as UDCT). Competent and experienced leadership team to steer growth
Supplier other products
Recommended supplier
-
VIP1年
- Jaksh Castor Products Pvt Ltd
- 141-22-0 98%
- Inquiry
- 2024-03-15
-
VIP1年
- Jayant Agro Organics Limited
- 141-22-0 Ricinoleic acid 99%
- Inquiry
- 2024-03-12
-
VIP1年
- Girnar Industries
- 141-22-0 98%
- Inquiry
- 2024-02-08
-
VIP1年
- Guru Raghvendra Chemicals
- 141-22-0 Ricinoleic acid 99%
- Inquiry
- 2024-01-27
-
VIP1年
- TGV SRAAC Ltd.
- Ricinoleic acid 141-22-0 98%
- Inquiry
- 2024-01-22
-
VIP1年
- Arvalli Castor Derivatives Pvt Ltd
- 141-22-0 98%
- Inquiry
- 2024-01-19
-
VIP1年
- Kisan Agro
- 141-22-0 Ricinoleic acid 98%
- Inquiry
- 2024-01-17
-
VIP1年
- Sree Rayalaseema HI Strength Hypo Ltd
- Ricinoleic acid 141-22-0 99%
- Inquiry
- 2024-01-05
-
VIP1年
- Ultra Chemical Works
- Ricinoleic Acid 99%
- Inquiry
- 2024-01-02
-
VIP1年
- Arvalli Castor Derivatives Pvt Ltd
- Ricinoleic acid 98%
- Inquiry
- 2024-01-19
- Since:2021-03-01
- Address: "Fantasia Business Park,_x000D_ F-17 (1st floor),_x000D_ Sector 30-A, Near Vashi Station,Vashi, Na
INQUIRY